Johnson & Johnson says it has reached an agreement with the Trump administration to lower drug prices for Americans. In exchange, the company will receive an exemption from U.S. tariffs on pharmaceuticals.
J&J plans to participate in the TrumpRx.gov program and promise “more comparable” prices; additionally, the company announced two new factories in Pennsylvania and North Carolina as part of its $55 billion U.S. investment plan.